Page last updated: 2024-08-21

alpha-aminopyridine and Esophageal Reflux

alpha-aminopyridine has been researched along with Esophageal Reflux in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Houwen, RHJ; Slae, M; van der Woerd, WL; Wilschanski, M1
Aihara, T; Hirao, A; Kato, T; Kurebayashi, Y; Mori, H; Ochi, Y; Ohshiro, H; Sakakibara, M; Takahashi, N; Taniguchi, Y; Tonai-Kachi, H1

Reviews

1 review(s) available for alpha-aminopyridine and Esophageal Reflux

ArticleYear
Effects of new and emerging therapies on gastrointestinal outcomes in cystic fibrosis.
    Current opinion in pulmonary medicine, 2017, Volume: 23, Issue:6

    Topics: Aminophenols; Aminopyridines; Benzodioxoles; Body Mass Index; Chloride Channel Agonists; Cystic Fibrosis; Digestive System; Drug Combinations; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Intestinal Diseases; Liver Diseases; Probiotics; Quinolones; Treatment Outcome; Weight Gain

2017

Other Studies

1 other study(ies) available for alpha-aminopyridine and Esophageal Reflux

ArticleYear
N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide (PF-03716556), a novel, potent, and selective acid pump antagonist for the treatment of gastroesophageal reflux disease.
    The Journal of pharmacology and experimental therapeutics, 2009, Volume: 328, Issue:2

    Topics: Aminopyridines; Animals; Anti-Ulcer Agents; Benzopyrans; Disease Models, Animal; Dogs; Enzyme Inhibitors; Gastroesophageal Reflux; Humans; Omeprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Stomach; Swine

2009